NIH CONSENSUS DEVELOPMENT CONFERENCES
\ˌɛnˌa͡ɪˈe͡ɪt͡ʃ kənsˈɛnsəs dɪvˈɛləpmənt kˈɒnfɹənsɪz], \ˌɛnˌaɪˈeɪtʃ kənsˈɛnsəs dɪvˈɛləpmənt kˈɒnfɹənsɪz], \ˌɛ_n_ˌaɪ_ˈeɪ_tʃ k_ə_n_s_ˈɛ_n_s_ə_s d_ɪ_v_ˈɛ_l_ə_p_m_ə_n_t k_ˈɒ_n_f_ɹ_ə_n_s_ɪ_z]\
Sort: Oldest first
-
Articles on conferences sponsored by NIH presenting summary statements representing the majority agreement of physicians, scientists, and other professionals convening for the purpose of reaching a consensus on a subject of interest. This heading is used for NIH consensus conferences as a means of scientific communication. In indexing it is viewed as a type of review article and as a tag for any article appearing in any publication of the NIH Office of Medical Applications of Research (OMAR).
By DataStellar Co., Ltd
Word of the day
Proto Oncogene Proteins c erbB 2
- cell surface protein-tyrosine kinase that is found to be overexpressed in significant number adenocarcinomas. It has extensive homology can heterodimerize EGF EPIDERMAL GROWTH FACTOR), 3 receptor (RECEPTOR, 3) and the 4 receptor. Activation of erbB-2 receptor occurs during heterodimer formation with a ligand-bound erbB family members. EC 2.7.11.-.
Nearby Words
- nigrosine
- nigua
- nih
- nih 3t3 cell
- nih 3t3 cells
- NIH Consensus Development Conferences
- nih office of scientific integrity
- nih10567
- nihau
- nihau island
- nihil